Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Apple
AAPL
|
+$953M |
| 2 |
NVIDIA
NVDA
|
+$784M |
| 3 |
Meta Platforms (Facebook)
META
|
+$753M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$316M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$315M |
Top Sells
| 1 |
Amazon
AMZN
|
+$1.17B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$506M |
| 4 |
Abbott
ABT
|
+$388M |
| 5 |
Johnson & Johnson
JNJ
|
+$325M |
Sector Composition
| 1 | Technology | 20.29% |
| 2 | Healthcare | 16.94% |
| 3 | Consumer Discretionary | 12.83% |
| 4 | Consumer Staples | 9.16% |
| 5 | Industrials | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BWIN
2076
Baldwin Insurance Group
BWIN
$2.22B
| $1.78M | ﹤0.01% |
72,000
+22,300
| +45% | +$553K |
|
|
DNB
2077
DELISTED
Dun & Bradstreet
DNB
| $1.78M | ﹤0.01% |
+153,800
| New | +$1.78M |
|
2078
Compass Minerals
CMP
$753M
| $1.78M | ﹤0.01% |
+52,200
| New | +$1.78M |
|
2079
Transcat
TRNS
$697M
| $1.77M | ﹤0.01% |
20,800
-1,700
| -8% | -$145K |
|
2080
Hyster-Yale Materials Handling
HY
$634M
| $1.77M | ﹤0.01% |
31,700
+15,900
| +101% | +$888K |
|
2081
Skyward Specialty Insurance
SKWD
$1.87B
| $1.77M | ﹤0.01% |
+69,693
| New | +$1.77M |
|
|
GAU
2082
Galiano Gold
GAU
$654M
| $1.76M | ﹤0.01% |
2,984,577
+250,624
| +9% | +$148K |
|
2083
abrdn Physical Platinum Shares ETF
PPLT
$1.64B
| $1.75M | ﹤0.01% |
20,958
+16,258
| +346% | +$1.36M |
|
|
WTT
2084
DELISTED
Wireless Telecom Group, Inc.
WTT
| $1.75M | ﹤0.01% |
834,244
+64,600
| +8% | +$136K |
|
2085
Cidara Therapeutics
CDTX
$1.66B
| $1.75M | ﹤0.01% |
77,479
+14,640
| +23% | +$331K |
|
|
AAN
2086
DELISTED
The Aaron's Company, Inc.
AAN
| $1.75M | ﹤0.01% |
123,400
-163,000
| -57% | -$2.3M |
|
2087
Security National Financial
SNFCA
$237M
| $1.74M | ﹤0.01% |
227,657
-8,150
| -3% | -$62.4K |
|
2088
Texas Capital Bancshares
TCBI
$3.98B
| $1.74M | ﹤0.01% |
33,800
+19,800
| +141% | +$1.02M |
|
|
PNT
2089
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $1.73M | ﹤0.01% |
190,975
-100,725
| -35% | -$912K |
|
2090
Upbound Group
UPBD
$1.45B
| $1.73M | ﹤0.01% |
55,512
-7,200
| -11% | -$224K |
|
2091
PDF Solutions
PDFS
$765M
| $1.72M | ﹤0.01% |
38,200
+14,400
| +61% | +$650K |
|
2092
Pinnacle Financial Partners
PNFP
$7.55B
| $1.72M | ﹤0.01% |
30,296
-48,275
| -61% | -$2.73M |
|
|
DCBO
2093
Docebo
DCBO
$869M
| $1.71M | ﹤0.01% |
43,400
+1,400
| +3% | +$55.2K |
|
2094
Kodak
KODK
$486M
| $1.71M | ﹤0.01% |
370,049
+41,949
| +13% | +$194K |
|
|
MTTR
2095
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $1.71M | ﹤0.01% |
542,700
-817,300
| -60% | -$2.58M |
|
2096
Interface
TILE
$1.66B
| $1.71M | ﹤0.01% |
194,200
+57,300
| +42% | +$504K |
|
2097
Precigen
PGEN
$1.13B
| $1.71M | ﹤0.01% |
1,483,590
-707,200
| -32% | -$813K |
|
|
DOYU
2098
DouYu International Holdings
DOYU
$231M
| $1.7M | ﹤0.01% |
162,043
-7,025
| -4% | -$73.7K |
|
2099
Avita Medical
RCEL
$123M
| $1.7M | ﹤0.01% |
100,000
-112,336
| -53% | -$1.91M |
|
|
DCPH
2100
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.7M | ﹤0.01% |
120,600
-110,718
| -48% | -$1.56M |
|